OBJECTIVE: Describe the management and evaluate the outcome of patients with laryngomalacia (LM) and simultaneous vocal cord dysfunction (VCD). METHOD: Children with LM and VCD treated at our tertiary referral center from 2003-2009 were reviewed retrospectively. Main outcome measures include resolution of VCD, polysomnography (PSG) parameters, swallow study reports, and changes in breathing and eating after treatment. RESULTS: Seven children were reviewed. Six patients had partial bilateral paralysis and one patient had a paradoxical vocal cord dysfunction. A third airway lesion was found in two patients. All patients were treated with reflux therapy. Five patients were treated with supraglottoplasty (SGP), and one patient was treated with Botox injections. Two of the three patients with PSG studies pre-and post-SGP showed improvement in AHI and O2 nadir. While breathing did improve in six patients after their primary treatment, one patient required a laryngotracheal reconstruction, one required an adenotonsillectomy, and two patients required a tracheostomy for aspiration. Both patients treated without SGP and less than half of those treated with SGP required a percutaneous gastrostomy tube. Six (86%) patients were ultimately eating without aspiration according to caregiver reports and swallow studies in follow-up (mean 11.4 months). VCD resolved completely in three patients, all of whom underwent SGP. CONCLUSION: The two most common causes of stridor in children may occur simultaneously. While the management is often multifactorial, a SGP may improve airway obstruction without increasing the risk of aspiration and should be considered as a first line treatment in many of these patients.
Laryngopharyngeal Reflux in a Gastroenterology Practice
Boris Bentsianov, MD (presenter); Bhawna Halwan, MSc, MD OBJECTIVE: 1) Learn the prevalence of laryngopharyngeal reflux (LPR) in patients seen by a gastroenterologist for gastroesophageal reflux (GERD). 2) Understand the ramifications that this may have on patient care as well as referral practices.
3) Assess a possible connection between LPR and hiatal hernia. METHOD: All patients seen by a gastroenterology group at an endoscopy center over a two year period were screened for a diagnosis of GERD. All charts were reviewed and patients were divided into those with hiatal hernia, those without, and those of whom it is unknown. Attempts were made to conduct a telephone survey using the Reflux Symptom Index (RSI), a validated index used to assess for LPR. RESULTS: 164 patients were studied. A telephone survey was completed by 73 patients (44%). 22 of those (30%) had an RSI greater than 13, strongly suggestive of LPR. There was no significant difference in RSI between patients with and without hiatal hernia. CONCLUSION: A significant proportion of patients seen in a gastroenterology practice (30%) were found to have symptoms strongly suggestive of LPR. These patients are being undertreated and should be referred to an otolaryngologist for management as well. There was no difference seen in LPR symptom prevalence in patients with hiatal hernia, but further research is warranted.
Local Steroid Injection in Patients with Vocal Nodule
Jang-Ok Yeo, MD (presenter); Se-Hyung Huh, MD; Sang-Hyuk Lee, MD, PhD OBJECTIVE: Steroids have marked anti-inflammatory and anti-edema actions. Local administration of steroid directly into the larynx has been reported in many laryngeal diseases such as vocal nodule, polyp, sarcoidosis and granuloma. This study reviews the results of steroid injection in 40 vocal cord nodule patients in an office setting. METHOD: Between December 2008 and September 2009, 40 patients with vocal nodules were enrolled in the study. Triamcinolone acetonide suspension(40mg/mL) was injected through the cricothyroid membrane with a transnasal flexible laryngoscope in the sitting position. Results were evaluated by morphologic evaluations using stroboscope, by comprehensive voice evaluations, and by self-assessment evaluations using Voice Handicap Index before and after injection. Pre-vs postinjection ratings were compared by paired student t-test (p values Ͻ 0.05).
RESULTS:
The operation was completed smoothly in 40 patients, typically within 15 minutes. The overall response rate by stroboscopy was 93% (37 of 40 patients) and complete remission rate was 50% (20 of 40). Jitter, Shimmer and Mean voice handicap index (pϽ0.05) also improved significantly after percutaneous steroid injection. CONCLUSION: Local steroid injection via cricothyroid membrane is an effective and useful treatment option of vocal nodules. Vocal nodules are generated based on vocal abuse and they easily recur unless the habit of vocal abuse is changed. So the combination of post-operative voice therapy with steroid injection may be important.
Methotrexate Therapy for Idiopathic Subglottic Stenosis
Daniel Fink, MD (presenter); Chih-Kwang Sung, MD, MS; Ramon Franco, MD OBJECTIVE: Idiopathic subglottic stenosis (ISS) is a complex problem for which the ideal solution has yet to be developed. Surgical management typically consists of laryngeal dilation, laryngotracheoplasty or laryngotracheal resection with primary anastomosis. Often, surgical management requires multiple interventions due to recurrence of stenosis. In addition, there are the surgical risks of recurrent laryngeal nerve injury, vocal fold scarring and dehiscence of anastomosis. No proven medical alternative for ISS is available. Methotrexate is a mainstay of treatment for Wegener's granulomatosis as well as other autoimmune disorders. We conducted a preliminary evaluation of methotrexate for the treatment of ISS. METHOD: A retrospective review was performed of patients with biopsy proven recurring ISS from September 2001 to May 2008 who were treated with methotrexate. Patients received 15-25 mg each week, corresponding to typical doses used for Wegener's. RESULTS: Four female patients with ISS, average age 44.8 years (range 29-62), were included. Patients received methotrexate 15-20 mg orally every week. One patient was changed from 20 mg orally to 25 mg subcutaneous injection due to ineffectiveness. Treatment duration averaged 17.8 months (range three to 33). Three of four patients reported improvements in breathing that worsened after discontinuation of the drug. One patient had progression of stenosis. No severe adverse effects were reported. CONCLUSION: Our initial trial of methotrexate for ISS improved breathing symptoms in 75% of patients while on therapy. Further evaluation of optimal dosing and long-term results should be considered.
Narrow Band Imaging in Recurrent Laryngeal Papillomatosis
Neil Tan, MBBS, MRCS, DO-HNS (presenter); Roberto Puxeddu, MD, FRCS OBJECTIVE: A pilot study to evaluate the diagnostic gain of Narrow Band Imaging in the early detection of recurrent laryngeal papillomatosis, and its use for intraoperative targeted treatment. METHOD: Study Design: A prospective study of Narrow Band Imaging Technology from March -December, 2009 in 12 patients with known primary or recurrent laryngeal papillomatosis who had undergone surgical treatment with either CO2 laser ablation or debridement and/or injection of Cidofovir to laryngeal papillomatosis. Methods: In the outpatient clinic all subjects were examined with fiber optic nasendoscopy using White Light Imaging (WLI) and the location and size of any papillomata were noted. Subsequently the Narrow Band Imaging (NBI) system was applied and any further suspicious lesions were annotated. Any operative management was planned using the information from both white light and Narrow Band Imaging. During microlaryngoscopy the use of rigid scope 0 and 45 degree were also used with both WLI and NBI. NBI was used in the operating theater for the accurate, targeted injection of intralesional cidofovir or surgical removal. RESULTS: Comparing WLI and NBI we were able to detect more significant papillomatosis in 3 patients (25%), this was confirmed at histology. Intraoperative NBI allowed us to identify small lesions accurately and inject cidofovir into all lesions. CONCLUSION: Narrow Band Imaging aids in the detection of early recurrent laryngeal papillomatosis allowing a more precise staging in 25% of cases, and allows for accurate targeting of intralesional cidofovir and/or surgical resection.
Objective Diagnostic Method in LPRD
Sei Young Lee, MD, PhD (presenter) OBJECTIVE: Investigate the possibility of using the damage to the reflux protective mechanism, which are known to be the etiology of Laryngopharyngeal Reflux Disease (LPRD), for objectively diagnosing this disease. METHOD: 28 patients who underwent laryngeal microsurgery due to benign laryngeal disease from March to August 2009, and who consented to participate in the study were included. Their reflux symptom indexes (RSI) and reflux finding scores (RFS) were measured and they were assigned either to the LPRD group (nϭ10) or to the control group (nϭ18). Tissue samples were obtained from the mucosa of the posterior commissure, and immunohistochemical staining (IHC) of CA Ϫ and Hsp 70 was performed. The IHC scores were measured and compared with clinical features including RSI and RFS.
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